GENEVA--(BUSINESS WIRE)-- Regulatory News: Alcon (SIX/NYSE:ALC), the global leader in eye care announced AcrySof® IQ Vivity®, a first-of-its-kind intraocular lens (IOL) is now commercially available ...

Vivity complements Alcon’s existing IOL portfolio by providing an additional option for cataract patients to treat presbyopia A first-of-its-kind, non-diffractive lens that offers a continuous ...

FORT WORTH, Texas--(BUSINESS WIRE)-- Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today proudly announces AcrySof® IQ Vivity® and Clareon® Vivity ...

TORONTO, Nov. 17, 2020 /CNW/ - Alcon, the global leader in eye care, is pleased to announce the Canadian launch of AcrySof ® IQ Vivity ®, a first-of-its-kind, surgical lens designed to help cataract ...

Alcon ALC recently announced that its Clareon Vivity intraocular lens (IOL), featuring extended depth of focus (EDOF) technology, has received CE Mark approval. The lens, made from Alcon's advanced ...

For almost 20 years now, we have been using presbyopia-correcting lens implants. But an important caveat that came with all of them is that they can only be used safely in eyes with near-perfect ...

Please provide your email address to receive an email when new articles are posted on . MILAN — In difficult eyes or eyes with comorbidities in which diffractive trifocal IOLs are not an option, the ...

Two specialists at Phoenix-based Valley Eye Specialists were among the first group of surgeons in the nation to implant the Alcon Acrysof IQ Vivity Lens after FDA approval, according to a Feb. 1 news ...